Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9RMR

Crystal structure of RXR alpha LBD bound to a synthetic agonist FN558 and a coactivator fragment

This is a non-PDB format compatible entry.
Summary for 9RMR
Entry DOI10.2210/pdb9rmr/pdb
DescriptorRetinoic acid receptor RXR-alpha, Nuclear receptor coactivator 2, FN558, ... (4 entities in total)
Functional Keywordsinhibitor, nuclear receptor, rxra, drug, transcription factor, ligand binding domain, transcription
Biological sourceHomo sapiens (human)
More
Total number of polymer chains2
Total formula weight28099.51
Authors
Morozov, V.,Nawa, F.,Merk, D. (deposition date: 2025-06-18, release date: 2025-08-13, Last modification date: 2025-08-27)
Primary citationNawa, F.,Kardanov, A.,Kasch, T.,Lewandowski, M.,Wein, T.,Hofner, G.,Marschner, J.A.,Morozov, V.,Merk, D.
Development of an RXR Agonist Scaffold with Pronounced Homodimer Preference.
J.Med.Chem., 68:16172-16187, 2025
Cited by
PubMed Abstract: The activation of retinoid X receptors (RXRs) presents promising therapeutic potential in diverse conditions, such as cancer, inflammation, metabolic dysfunction, and neurodegeneration. However, RXRs play a central role in nuclear receptor signaling and act in various dimeric forms with multiple other ligand-activated transcription factors giving rise to promiscuous effects of RXR agonists. Here we identified a new RXR ligand chemotype addressing only part of RXR's molecular activities. Optimization provided a new RXR modulator scaffold fully activating the RXR homodimer with nanomolar potency but displaying markedly reduced RXR heterodimer activation compared to bexarotene. Co-crystal structure analysis revealed different molecular effects on the RXR LBD conformation than bexarotene possibly mediating the selective activity. The new RXR modulator type enables studies on selective RXR homodimer activation effects and suggests that different molecular mechanisms of RXR activity can be selectively addressed with ligands.
PubMed: 40704597
DOI: 10.1021/acs.jmedchem.5c01090
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.65 Å)
Structure validation

242199

PDB entries from 2025-09-24

PDB statisticsPDBj update infoContact PDBjnumon